top of page

Click on the Poster to View Larger

Search by
Poster Number

Poster 10

Jun 9, 2024

1 min read

Updated: Jun 27, 2024

Pooled patient-reported outcomes from the Phase 3 THRIVE-AA1 and THRIVE-AA2 trials of deuruxolitinib in adult patients with moderate-to-severe alopecia areata

Authors: Natasha A. Mesinkovska; Maryanne Makredes Senna; Brett King; Arash Mostaghimi; Colleen Hamilton; James Cassella

<PREVIOUS POSTER | NEXT POSTER>

Poster 10

01, 02, 03, 04, 05, 06, 07, 08, 09, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64

bottom of page